Search

Cobra Leadership Team


Peter Coleman FCMA, MBA

Peter Coleman FCMA, MBA

CEO

Prior to his appointment as CEO in May 2011, Peter was Finance Director at Cobra and Recipharm Ltd, Ashton. Peter was also Finance Director of Cobra Biomanufacturing Plc up to its acquisition by Recipharm in 2010, and he has been at the Keele facility for more than 9 years.

Prior to Cobra he was employed in a number of senior financial and corporate development roles. Peter was awarded an MBA with distinction jointly from the Manchester Business School and the University of Wales.

Daniel Smith PhD

Daniel Smith PhD

CSO

Prior to his appointment as CSO in June 2014, Daniel was a Knowledge Transfer Manager and Senior Technologist for 4 years within the bioProcessUK team at the HealthTech & Medicines Knowledge Transfer Network.

Formerly, Daniel spent 5 years at Cobra in roles including Senior Scientist, QC Team Leader, Head of Process Technology Transfer and Commercial Scientific Development Manager. He has over 8 years academic research experience, 20+ research publications to his name and a PhD in Molecular Cell Biology.

Jason Rahal

Jason Rahal

Senior VP Business Development

Jason has over 25 years of experience in biotechnology. Prior to joining Cobra, Jason worked at Excell Biotech in Edinburgh, Scotland and Stratagene Cloning Systems in La Jolla, CA in various business development and sales positions. Jason has a strong background in molecular biology, beginning his career at Northwestern University in Evanston, IL managing a molecular endocrinology laboratory with several peer reviewed publications.

Jason was appointed as Vice President Business Development at Cobra in 2002 and promoted to SVP Business Development in 2006.

Jason holds a BA in Biology and Studio Art from Knox College.

Lars Fahlander MSc

Lars Fahlander MSc

Site Manager, Matfors

Lars has extensive senior management experience; he has held the position of CEO at a number of companies and has been both a Board Member and Chairman on several Boards of Directors. Ten years ago, Lars formed his own Management Consultancy company active in a number of entrepreneurial fields in different business areas such as manufacturing, foundries, telecom, television and IT.

Lars holds an MSc in Industrial Economy from the University of Linköping.

Magnus Gustafsson MSc, PhD, MBA

Magnus Gustafsson MSc, PhD, MBA

Sales Director

Prior to joining Cobra’s facility in Södertälje in 2008, Magnus worked for AstraZeneca and Gyros. He has a strong scientific background, with more than 20 peer-reviewed articles, and has spent 15 years in various commercial positions executing intra- and extra scientific and corporate collaborations, sales management, project management, business development, partnership negotiations and agreements.

Magnus holds an MSc in Biochemical Engineering, a PhD in Protein Science and an MBA in Business Administration.

Philip Ridley-Smith

Philip Ridley-Smith

Sales and Marketing Director

Philip joined Cobra in 2004 and is currently responsible for sales activities in Europe and Asia. In addition, he oversees the global marketing of Cobra with its 3 sites in Europe.

Before Cobra, Philip had 10 years of experience in various sales positions for diagnostics, large pharma and FMCG companies working in Europe and Asia.

Philip holds a BSc in Biology and French with a CIM qualification.

Sheena Pumford CIPD

Sheena Pumford CIPD

HR Director

After completing a management training course with a large retail organisation, Sheena was seconded to a training role with responsibility for the training of over 100 staff and management.

In 1997 Sheena joined Therexsys (now Cobra Biologics) to set up a Personnel Department providing advice to staff and management on a wide range of personnel and training issues. She has spent the last fourteen years in the role and during this time has completed an NVQ Level 4 in Personnel Management.

Steve Garland

Site Manager, Keele

As a microbiologist with over 35 years of biologics development and manufacturing experience Steve joined Cobra in 2014.

He has held several senior positions in manufacturing, commercial and facility management at Celltech, Johnson and Johnson in the Netherlands (formerly Centocor), Sanofi Aventis and more recently Novozymes. Steve has led technology transfer projects into and from the UK to the USA, Japan and China including involvement in the design and build of manufacturing facilities in Asia.

Steve has significant experience in managing facilities through successful Regulatory Authority audits; pre-approval audits, GMP certificate audits and routine inspections.

Ulrika Ljungkvist MSc

Ulrika Ljungkvist MSc

Site Manager, Södertälje

Ulrika Ljungkvist has more than 18 years of experience in API manufacturing, both with commercial (small molecules) and development manufacturing (biologics) for AstraZeneca, and now Cobra Biologics in Sweden. Ulrika joined Astra in 1995 and transferred to Recipharm Biologics Södertälje in 2009 as Director Operations. Ulrika became Site Manager in 2010.

Ulrika holds an M.Sc. in Chemical Engineering from the Royal Institute of Technology.

In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site. It is recommended that you allow all cookies. Allow all cookies